Working in silos, change will not occur. WBC convenes with our Partners, Champions, and Sponsors to move faster together toward our action initiative goals.
Join us for Our Annual Action for Impact Summit!
WBC’s Annual Action for Impact Summit unites thousands of attendees on a fully interactive platform, enabling participants to network, connect, and exchange ideas, innovations, and impact in real time.
WOMEN CEO REPORT
Kristin Yarema, Ph.D., is the CEO of Poseida Therapeutics, Inc., a biopharmaceutical company dedicated to developing innovative therapies for cancer and genetic diseases. Dr. Yaremas leadership is characterized by a commitment to advancing cutting-edge research, strategic clinical development, and improving patient outcomes. With extensive experience in biotechnology and drug development, she has guided Poseida Therapeutics through critical stages of research and clinical trials. Her focus on leveraging advanced technologies and fostering strategic partnerships continues to drive the companys mission and position Poseida Therapeutics at the forefront of biopharmaceutical innovation. Under her leadership, the company is making significant strides in developing transformative therapies for complex diseases.
